NCT03710239 (OPIOID) is a NA clinical trial of Dilapan-S in Abortion in Second Trimester, sponsored by Albany Medical College.

Who is sponsoring NCT03710239?

NCT03710239 is sponsored by Albany Medical College.

What drugs are being tested in NCT03710239?

Interventions in NCT03710239: Dilapan-S, Laminaria.

What condition does NCT03710239 study?

NCT03710239 studies Abortion in Second Trimester.

Is NCT03710239 still recruiting?

NCT03710239 is currently completed. Last updated 16 March 2020.

Last reviewed 2020-03-16 · How we verify

NCT03710239: OPIOID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OPIOID Study - Pain With Osmotic Dilators

Completed NA Last updated 16 March 2020

What this trial tests

NA trial testing Dilapan-S in Abortion in Second Trimester in 68 participants. Completed in 11 March 2020.

Timeline

2 October 2018

Primary endpoint
11 March 2020

11 March 2020

Quick facts

Lead sponsor	Albany Medical College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	68
Start date	2 October 2018
Primary completion	11 March 2020
Estimated completion	11 March 2020
Sites	1 location across United States

Drugs / interventions tested

Dilapan-S
Laminaria

Conditions studied

Abortion in Second Trimester — all drugs for Abortion in Second Trimester →

Sponsor

Albany Medical College

Who can join

18 and older, female only, with Abortion in Second Trimester. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of pain levels and pain medications utilized following insertion of two different types of osmotic dilators.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dilapan-S

Trials testing the same drug.

NCT05062343 — Cook Balloon vs Dilapan-S for Outpatient Cervical Ripening · NA · completed
NCT05099991 — Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion · NA · completed
NCT04451109 — Dilapan-S®: A Multicenter US E-registry · active not recruiting
NCT03001661 — An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt · Phase 3 · completed

Other Albany Medical College trials

Trials by the same sponsor.

NCT07373093 — Predictors of Measles Vaccine Hesitancy in New York State · completed
NCT06517901 — Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer · NA · recruiting
NCT06668766 — Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED · NA · recruiting
NCT06677541 — Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients · NA · recruiting
NCT02703610 — Randomized Trial of Two Analgesics in Elderly ED Patients · Phase 4 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03710239 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Albany Medical College
Last refreshed: 16 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03710239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing